Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) were down 7.4% during mid-day trading on Wednesday . The company traded as low as $0.19 and last traded at $0.22. Approximately 103,096 shares changed hands during trading, an increase of 412% from the average daily volume of 20,150 shares. The stock had previously closed at $0.24.
Alpha Tau Medical Stock Performance
The company’s 50 day moving average price is $0.29 and its 200 day moving average price is $0.24.
About Alpha Tau Medical
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Stories
- Five stocks we like better than Alpha Tau Medical
- Roth IRA Calculator: Calculate Your Potential Returns
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- The 3 Most Talked About Investments on WallStreetBets Right Now
- A Deeper Look at Bid-Ask Spreads
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
